Cargando…
Naotaifang extract treatment results in increased ferroportin expression in the hippocampus of rats subjected to cerebral ischemia
The expression of Ferroportin (Fpn) was examined at different time points in rats following focal cerebral ischemia treated with or without the traditional Chinese medicine Naotaifang. Initially, rats were randomly divided into 2, 6, 12, 24 and 72 h groups following middle cerebral artery occlusion...
Autores principales: | LIAO, JUN, XIA, XING, WANG, GUO-ZUO, SHI, YONG-MEI, GE, JIN-WEN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394947/ https://www.ncbi.nlm.nih.gov/pubmed/25672910 http://dx.doi.org/10.3892/mmr.2015.3309 |
Ejemplares similares
-
Naotaifang extract treatment results in increased ferroportin expression in the hippocampus of rats subjected to cerebral ischemia
por: Liao, Jun, et al.
Publicado: (2016) -
Metabonomics Study on Naotaifang Extract Alleviating Neuronal Apoptosis after Cerebral Ischemia-Reperfusion Injury
por: Xu, Dehong, et al.
Publicado: (2022) -
An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury
por: Yang, Tong, et al.
Publicado: (2021) -
Naotaifang III Protects Against Cerebral Ischemia Injury Through LPS/TLR4 Signaling Pathway in the Microbiota–Gut–Brain Axis
por: Nie, Huifang, et al.
Publicado: (2023) -
Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial
por: Fang, Rui, et al.
Publicado: (2023)